Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) kicked off on Friday, up 10.32% from the previous trading day, before settling in for the closing price of $8.43. Over the past 52 weeks, AMLX has traded in a range of $2.05-$8.72.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales slid by -78.71% over the last five years. While this was happening, its average annual earnings per share was recorded 59.50%. With a float of $66.52 million, this company’s outstanding shares have now reached $89.16 million.
Amylyx Pharmaceuticals Inc (AMLX) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Amylyx Pharmaceuticals Inc is 25.40%, while institutional ownership is 84.76%. The most recent insider transaction that took place on Aug 13 ’25, was worth 125,046. In this transaction Chief Legal Officer of this company sold 15,000 shares at a rate of $8.34, taking the stock ownership to the 156,969 shares. Before that another transaction happened on Aug 12 ’25, when Company’s Chief Legal Officer sold 15,000 for $8.07, making the entire transaction worth $121,102. This insider now owns 171,969 shares in total.
Amylyx Pharmaceuticals Inc (AMLX) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 59.50% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.07% during the next five years compared to -78.71% drop over the previous five years of trading.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Trading Performance Indicators
Take a look at Amylyx Pharmaceuticals Inc’s (AMLX) current performance indicators. Last quarter, stock had a quick ratio of 8.72.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.50, a number that is poised to hit -0.46 in the next quarter and is forecasted to reach -1.46 in one year’s time.
Technical Analysis of Amylyx Pharmaceuticals Inc (AMLX)
Analysing the last 5-days average volume posted by the [Amylyx Pharmaceuticals Inc, AMLX], we can find that recorded value of 1.47 million was better than the volume posted last year of 1.11 million. As of the previous 9 days, the stock’s Stochastic %D was 81.07%.
During the past 100 days, Amylyx Pharmaceuticals Inc’s (AMLX) raw stochastic average was set at 98.76%, which indicates a significant increase from 95.89% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.44 in the past 14 days, which was higher than the 0.42 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $7.37, while its 200-day Moving Average is $5.08. Now, the first resistance to watch is $9.63. This is followed by the second major resistance level at $9.96. The third major resistance level sits at $10.55. If the price goes on to break the first support level at $8.71, it is likely to go to the next support level at $8.13. Should the price break the second support level, the third support level stands at $7.80.
Amylyx Pharmaceuticals Inc (NASDAQ: AMLX) Key Stats
The company with the Market Capitalisation of 829.28 million has total of 89,167K Shares Outstanding. Its annual sales at the moment are 87,370 K in contrast with the sum of -301,740 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -41,440 K.
